Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Tumor Susceptibility Gene 101 (TSG101) (N-Term) Peptid

TSG101 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN2183454
  • Target Alle TSG101 Produkte
    TSG101 (Tumor Susceptibility Gene 101 (TSG101))
    Protein Region
    N-Term
    Spezies
    Human
    Quelle
    • 8
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    YKYRDLTVRE TVNVITLYKD LKPVLDSYVF NDGSSRELMN LTGTIPVPYR
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-TSG101 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeat freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    TSG101 (Tumor Susceptibility Gene 101 (TSG101))
    Hintergrund
    The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression.

    Alias Symbols: TSG10, VPS23

    Protein Size: 390
    Molekulargewicht
    44 kDa
    Gen-ID
    7251
    NCBI Accession
    NM_006292, NP_006283
    UniProt
    Q99816
Sie sind hier:
Kundenservice